Observational Study Evaluating Long-term Health Outcomes of Canadian DUODOPA-treated Patients
NCT02485600 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88
Last updated 2021-06-25
Summary
This is an open-label, postmarketing, observational study to document health outcomes, in Canadian patients with advanced Parkinson's disease and long-term treatment with Duodopa (levodopa/carbidopa intestinal gel).
Conditions
- Parkinson Disease (PD)
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
AbbVie Inc. · AbbVie
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-19
- Primary Completion
- 2020-02-26
- Completion
- 2020-02-26
Countries
- Canada
Study Locations
More Related Trials
-
Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States
NCT00143026 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Safety and Efficacy of Levodopa-carbidopa Intestinal Gel (LCIG) for the Treatment of Non-motor Symptoms in Patients With Advanced Parkinson's Disease
NCT01736176 ·Status: COMPLETED ·Phase: PHASE3
-
Asymmetric Subthalamic Deep Brain Stimulation for Axial Motor Dysfunction in Parkinson's Disease
NCT03462082 ·Status: COMPLETED ·Phase: NA
-
Duodopa Home Titration Using Telemedicine: Evaluation of Use of Resources
NCT01956032 ·Status: COMPLETED
-
Clinical and Economic Impact of Duodopa: Long-term Effectiveness Study in Advanced Parkinson's Disease Patients
NCT01291537 ·Status: COMPLETED ·Phase: PHASE2
-
A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease
NCT01484990 ·Status: COMPLETED ·Phase: PHASE1
-
Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants Earlier Within Advanced Parkinson Disease
NCT07227896 ·Status: NOT_YET_RECRUITING
-
The Impact of Exercise on Subthalamic Nucleus Neural Activity in Parkinson's Disease
NCT05905302 ·Status: COMPLETED ·Phase: NA
-
Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease
NCT00404170 ·Status: COMPLETED ·Phase: PHASE2
-
Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa
NCT01754129 ·Status: COMPLETED
-
Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease
NCT00129181 ·Status: COMPLETED ·Phase: NA
-
Study of Dysarthria, and the Appearance of Non-dopaminergic Signs in Idiopathic PARKinson's Disease
NCT03517059 ·Status: COMPLETED
-
Study to Investigate the Ability of [11C]Donepezil PET to Image the Parasympathetic Nervous System
NCT01877538 ·Status: COMPLETED
-
Multi-centre UK Study of the Acetylcholinesterase Inhibitor Donepezil in Early Dementia Associated With Parkinson's Disease
NCT01014858 ·Status: TERMINATED ·Phase: PHASE3
-
LIPAD - LRRK2 International Parkinson's Disease Study
NCT04214509 ·Status: UNKNOWN
-
CANadian Adaptive DBS TriAl
NCT05402163 ·Status: RECRUITING ·Phase: NA
-
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
NCT02615873 ·Status: UNKNOWN ·Phase: PHASE3
-
[11C]Donepezil PET For Imaging The Autonomous Nervous System In Parkinsons Disease
NCT02012595 ·Status: COMPLETED
-
Weight Changes in Parkinsonian Patients, Treated With Deep Brain Stimulation
NCT00221793 ·Status: COMPLETED ·Phase: NA
-
ADvance II Study: DBS-f in Patients With Mild Alzheimer's Disease
NCT03622905 ·Status: COMPLETED ·Phase: NA
-
Guideline for Hometitration With Duodopa for Parkinson Patients
NCT04196647 ·Status: COMPLETED
-
Prodromal Alpha-Synuclein Screening in Parkinson's Disease Study
NCT04724941 ·Status: RECRUITING
-
Transdermal Rotigotine User Surveillance Study
NCT00599339 ·Status: COMPLETED
-
Observational, Long-term Extension Study for Participants of Prior VY-AADC01 Studies
NCT03733496 ·Status: COMPLETED
-
Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Motor Fluctuations
NCT01766258 ·Status: COMPLETED ·Phase: PHASE2